Thermo Fisher’s Q1 2025 earnings report revealed a performance as precise as a lab instrument. The company beat expectations ...

With the threat of Trump administration's tariffs swirling and biopharma companies bracing for impact, many are announcing ...

Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at ...

The science-services and instruments provider is expanding operations in the U.S. as companies rearrange manufacturing to avoid new global tariffs. The pharmaceutical industry has long been exempt ...

Raymond James lowered the firm’s price target on Thermo Fisher (TMO) to $525 from $667 and keeps an Outperform rating on the shares. Thermo ...

Stifel lowered the firm’s price target on Thermo Fisher (TMO) to $620 from $665 and keeps a Buy rating on the shares. Thermo “performed well” ...

The human identification market is projected to grow from USD 1.2 billion in 2023 to USD 3 billion by 2033, at a CAGR of 9.6% ...

Discover how the hybrid analysis approach drives innovation in materials. Read on for insights into EM and microCT.

We recently published a list of 10 Stocks in Wall Street’s Watchlist. In this article, we are going to take a look at where ...

The global titanium diboride industry is poised for substantial growth, with projections indicating a compound annual growth ...

Among the famous faces? Nicole Scherzinger, Cole Escola, Helen J Shen, Jordan Fisher, Ana Gasteyer and Death Becomes Her's dynamic duo: Megan Hilty and Jennifer Simard (among others).